BioCentury
ARTICLE | Clinical News

Votrient pazopanib regulatory update

August 13, 2012 7:00 AM UTC

The European Commission approved Votrient pazopanib from GlaxoSmithKline to treat advanced soft tissue sarcoma in patients who received prior chemotherapy or who have progressed in the last 12 months ...